The biocompatibility and separation performance of antioxidative polysulfone/vitamin E TPGS composite hollow fiber membranes

Biomaterials

Volumn 32, Issue 2, 2011, Pages 352-365

  Dahe, Ganpat J ^a   Teotia, Rohit S ^a   Kadam, Sachin S ^a   Bellare, Jayesh R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Biocompatibility; Hollow fibers; Solute rejection; TPGS; Ultrafiltration coefficient

Indexed keywords

ATR FTIR; CELLULAR ELEMENTS; COMPLEMENT ACTIVATIONS; COMPOSITE HOLLOW FIBER MEMBRANE; DOPE SOLUTION; DRY-WET SPINNING; EXTENDED INTERACTION; HEMODIALYSIS MEMBRANES; HIGH FLUX; HOLLOW FIBER; HOLLOW FIBER MEMBRANES; HYPERSENSITIVE REACTION; IN-VITRO; INFLAMMATORY RESPONSE; MICRO-DOMAINS; ORDERS OF MAGNITUDE; PLATELET ADHESION; PROTEIN ADSORPTION; REACTIVE OXYGEN SPECIES; SEM STUDY; SEPARATION PERFORMANCE; SOLUTE REJECTION; TPGS; VITAMIN-E;

ADSORPTION; BIOCOMPATIBILITY; BLOOD; DIALYSIS; FIBERS; HEMODIALYZERS; METABOLISM; OXYGEN; SPINNING (FIBERS); ULTRAFILTRATION; UREA;

COMPOSITE MEMBRANES;

ALPHA TOCOPHEROL; POLYSULFONE; REACTIVE OXYGEN METABOLITE; TOCOFERSOLAN; UREA;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCOMPATIBILITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; DIALYSIS MEMBRANE; HEMOLYSIS; HOLLOW FIBER MEMBRANE; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ADHESION; ULTRAFILTRATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; HEMOLYSIS; MEMBRANES, ARTIFICIAL; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; NIH 3T3 CELLS; PLATELET AGGREGATION; POLYETHYLENE GLYCOLS; POLYMERS; RENAL DIALYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONES; THERMOGRAVIMETRY; ULTRAFILTRATION; VITAMIN E;

EID: 78449261709     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.005     Document Type: Article

References (60)

1. Hakim R.M. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993, 44:484-494.
2. Janvier G., Baquey C., Roth C., Benillan N., Belisle S., Hardy J.F. Extracorporeal circulation, hemocompatibility, and biomaterials. Ann Thorac Surg 1996, 62:1926-1934.
3. Gorbet M.B., Sefton M.V.M. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004, 25:5681-5703.
4. Pastan S., Bailey J. Medical progress: dialysis therapy. New Engl J Med 1998, 338:1428-1437.
5. Cheung A.K. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990, 1:150-161.
6. Sirolli V., Ballone E., Di Stante S., Amoroso L., Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Int J Artif Organs 2002, 25:529-537.
7. Thijs A., Grooteman M.P.C., Zweegman S., Nube M.J., Huijgens P.C., Stehouwer C.D.A. Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes. Blood Purificat 2007, 25:389-394.
8. Renaux J.L., Thomas M., Crost T., Loughraieb N., Vantard G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. Kidney Int 1999, 55:1097-1103.
9. Singh N.P., Bansal R., Thakur A., Kohli R., Bansal R.C., Agarwal S.K. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study. Ren Fail 2005, 25:419-430.
10. Park J.Y., Acar M.H., Akthakul A., Kuhlman W., Mayes A.M. Polysulfone-graft-poly(ethylene glycol) graft copolymers for surface modification of polysulfone membranes. Biomaterials 2006, 27:856-865.
11. Khang G., Lee H.B., Park J.B. Biocompatibility of polysulfone I. Surface modifications and characterizations. Biomed Mater Eng 1995, 5:245-258.
12. Hayama M., Yamamoto K., Kohori F., Sakai K. How polysulfone dialysis membranes containing polyvinylpyrrolidone achieve excellent biocompatibility?. J Membr Sci 2004, 234:41-49.
13. Ishihara K., Fukumoto K., Iwasaki Y., Nakabayashi N. Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility. Part 2. Protein adsorption and platelet adhesion. Biomaterials 1999, 20:1553-1559.
14. Morena M., Delbosc S., Dupuy A.M., Canaud B., Cristol J.P. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005, 9:37-46.
15. Ward R.A., McLeish K.R. Oxidant stress in hemodialysis patients: what are the determining factors?. Artif Organs 2003, 27:230-236.
16. Himmelfarb J., Lazarus J.M., Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991, 17:271-276.
17. Mügge A. The role of reactive oxygen species in atherosclerosis. Z Kardiol 1998, 87:851-864.
18. Gwinner W., Grone H.J. Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transpl 2000, 15:1127-1132.
19. Tarng D.C., Huang T.P., Liu T.Y., Chen H.W., Sung Y.J., Wei Y.H. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000, 58:790-799.
20. Nakatan T., Takemoto Y., Tsuchida K. The effect of vitamin E-bonded dialyzer membrane on red blood cell survival in hemodialyzed patients. Artif Organs 2003, 27:214-217.
21. Tsuruoka S., Kawaguchi A., Nishiki K., Hayasaka T., Fukushima C., Sugimoto K., et al. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis 2002, 39:127-133.
22. Sasaki M., Hosoya N., Saruhashi M. Development of vitamin E-modified membrane. Vitamin E-bonded membrane a further step in dialysis optimization 1999, 49-70. Karger, Basel. C. Ronco, G. La Greca (Eds.).
23. Pertosa G., Grandaliano G., Valente M., Montinaro V., Soccio M., Gesualdo L., et al. In vivo evaluation of biocompatibility of a new dialyzer employing the vitamin E-modified cellulose membrane 'Excebrane E': study of mechanisms involved in mononuclear cell activation. Vitamin E-bonded membrane a further step in dialysis optimization 1999, 200-207. Karger, Basel. C. Ronco, G. La Greca (Eds.).
24. Sasaki M. Development of vitamin E-modified polysulfone membrane dialyzers. J Artif Organs 2006, 9:50-60.
25. Yamamoto K., Matsuda M., Okuoka M., Yakushiji T., Fukuda M., Miyasaka T., et al. Antioxidation property of vitamin E-coated polysulfone dialysis membrane and recovery of oxidized vitamin E by vitamin C treatment. J Membr Sci 2007, 302:115-118.
26. Kim K.S., Lee K.H., Cho K., Park C.E. Surface modification of polysulfone ultrafiltration membrane by oxygen plasma treatment. J Membr Sci 2002, 199:135-145.
27. Wacher V.J., Wong S., Wong H.T. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with d-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 2002, 91:77-90.
28. Krasavage W.J., Terhaar C.J. d-α-tocopheryl poly(ethylene glycol) 1000 succinate. Acute toxicity, subchronic feeding, reproduction, and teratologic studies in the rat. J Agr Food Chem 1977, 25:273-278.
29. Hoenich N.A., Stamp S., Roberts S.J. A microdomain-structured synthetic high- flux hollow-fiber membrane for renal replacement therapy. ASAIO J 2000, 46:70-75.
30. Unger R.E., Huang Q., Peters K., Protzer D., Paul D., Kirkpatrick C.J. Growth of human cells on polyethersulfone (PES) hollow fiber membranes. Biomaterials 2005, 26:1877-1884.
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
32. Groth T., Synowitz J., Malsch G., Richau K., Albrecht W., Lange K.P., et al. Contact activation of plasmatic coagulation on polymeric membranes measured by the activity of kallikrein in heparinized plasma. J Biomat Sci-Polym E 1997, 8:797-807.
33. Fushimi F., Nakayama M., Nishimura K., Hiyoshi T. Platelet adhesion, contact phase coagulation activation, and C5a generation of polyethylene glycol acid- grafted high flux cellulosic membrane with varieties of grafting amounts. Artif Organs 1998, 22:821-826.
34. Xu Z.L., Qusay F.A. Polyethersulfone (PES) hollow fiber ultrafiltration Membranes prepared by PES/non-solvent/NMP solution. J Membr Sci 2004, 233:101-111.
35. Mulder M. Basic principles of membrane technology 1996, Kluwer Academic Publisher, Dordrecht, pp. 293-296.
36. Cooper A.R., Van Derveer D.S. Characterization of ultrafiltration membranes by polymer transport measurements. Separ Sci Technol 1979, 14:551-556.
37. Schock G., Miquel A., Birkenberger R. Characterization of ultrafiltration membranes: cut-off determination by gel permeation chromatography. J Membr Sci 1989, 41:55-67.
38. Tkacik G., Michaels S. A rejection profile test for ultrafiltration membranes and devices. Biotechnol 1991, 9:941-946.
39. Buck RJ, Goehl HJ. Selectively permeable asymmetric membranes suitable for use in hemodialysis and processes for manufacturing such membranes, US Patent No 4935141, 1990.
40. Kim J.H., Lee K.H. Effect of PEG additive on membrane formation by phase inversion. J Membr Sci 1998, 138:153-163.
41. Wienk I.M., Van den Boomgaard T., Smolders C.A. Formation of nodular structures in the top layer of ultrafiltration membranes. J Appl Polym Sci 1994, 53:1011-1023.
42. Rajaraman R., Rounds D.E., Yen S.P.S., Rembaum A. A scanning electron microscope study of cell adhesion and spreading in vitro. Exp Cell Res 1974, 88:327-339.
43. Wattamwar P.P., Mo Y., Wan R., Palli R., Zhang Q., Dziubla T.D. Antioxidant activity of degradable polymer poly(trolox ester) to suppress oxidative stress injury in the cells. Adv Funct Mater 2010, 20:147-154.
44. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 6:1794-1807.
45. Simon H.U., Haj-Yehia A., Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5:415-418.
46. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992, 5:227-231.
47. Traber M.G., Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Bio Med 2007, 43:4-15.
48. Roberts L.J., Oates J.A., Linton M.F., Fazio S., Meador B.P., Gross M.D., et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Bio Med 2007, 43:1388-1393.
49. Andrade J.D., Hlady V. Plasma protein adsorption: the big twelve. Ann Ny Acad Sci 1987, 516:158-172.
50. Elbert D.L., Hubbell J.A. Surface treatments of polymers for biocompatibility. Annu Rev Mater Sci 1996, 26:365-394.
51. Gombotz W.R., Guanghui W., Horbett T.A., Hoffman A.S. Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res 1991, 25:1547-1562.
52. Higuchi A., Sugiyama K., Yoon B.O., Sakurai M., Hara M., Sumita M., et al. Serum protein adsorption and platelet adhesion on pluronic(TM)-adsorbed polysulfone membranes. Biomaterials 2003, 24:3235-3245.
53. Peerschke E.I., Zucker M.B., Grand R.A. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 1980, 55:841-847.
54. Bailly A.L., Laurent A., Lu H., Elalami I., Jacob P., Mundler O., et al. Fibrinogen binding and platelet retention: relationship with the thrombogenicity of catheters. J Biomed Mater Res 1996, 30:101-108.
55. Tanaka M., Motomura T., Kawada M., Anzai T., Yuu K., Shiroya T., et al. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)-relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000, 21:1471-1481.
56. Basmadjian D., Sefton M.V., Baldwin S.A. Coagulation on biomaterials in flowing blood: some theoretical considerations. Biomaterials 1997, 18:1511-1522.
57. Sanchez J., Elgue G., Larsson R., Nilsson B., Olsson P. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system. Thromb Res 2008, 122:257-263.
58. Deppisch R., Schmitt V., Bommer J., Hansch G.M., Ritz E., Rauterberg E.W. Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Kidney Int 1990, 37:696-706.
59. Tokars J.I., Alter M.J., Favero M.S., Moyer L.A., Bland L.A. National surveillance of dialysis associated diseases in the United States, 1991. ASAIO J 1993, 39:966-975.
60. Chauveau P., Nguyen H., Combe C., Chêne G., Azar R., Cano N., et al. Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005, 45:565-571.